References
- Guerre-Millo M. Adipose tissue hormones. J Endocrinol Invest. 2002;25(10):855–861.
- Filková M, Haluzík M, Gay S, et al. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol. 2009;133(2):157–170.
- Gómez R, Conde J, Scotece M, et al. What’s new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol. 2011;7(9):528–536.
- Sglunda O, Mann H, Hulejová H, et al. Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohort. PLoS One. 2014;9(7):e103495.
- Busso N, Karababa M, Nobile M, et al. pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS One. 2008;3(5):e2267.
- Gremese E, Tolusso B, Gigante MR, et al. Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases). Front Immunol. 2014;5:576.
- de Hair MJ, Landewe RB, van de Sande MG, et al. Smoking and overweight determine the likelihood of developing rheumatoid arthritis. Ann Rheum Dis. 2013;72:1654–1658.
- Mandl LA, Costenbader KH, Simard JF, et al. Is birthweight associated with risk of rheumatoid arthritis? Data from a large cohort study. Ann Rheum Dis. 2009;68(4):514–518.
- van der Helm-Van Mil AH, van der Kooij SM, Allaart CF, et al. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis. 2008;67(6):769–774.
- Maijer KI, Neumann E, Müller-Ladner U, et al. Serum vaspin levels are associated with the development of clinically manifest arthritis in autoantibody-positive individuals. PLoS One. 2015;10(12):e0144932.
- Giles JT, van der Heijde DM, Bathon JM. Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis. Ann Rheum Dis. 2011;70(9):1562–1568.
- Neumann E, Frommer KW, Vasile M, et al. Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases? Arthritis Rheum. 2011;63(5):1159–1169.
- Gonzalez-Gay MA, Llorca J, Garcia-Unzueta MT, et al. High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis. Clin Exp Rheumatol. 2008;26(4):596–603.
- Syrbe U, Callhoff J, Conrad K, et al. Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression. Arthritis Rheumatol. 2015;67(3):678–685.
- Eder L, Jayakar J, Pollock R, et al. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Ann Rheum Dis. 2013;72(12):1956–1961.
- Pina T, Genre F, Lopez-Mejias R, et al. Relationship of leptin with adiposity and inflammation and resistin with disease severity in psoriatic patients undergoing anti-TNF-alpha therapy. J Eur Acad Dermatol Venereol. 2015;29(10):1995–2001.
- Hulejová H, Kryštůfková O, Mann H, et al. Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients. Clin Exp Rheumatol. 2016;34(2):222–229.
- Tomčík M, Arima K, Hulejová H, et al. Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis. Cytokine. 2012;58(2):165–168.
- Vadacca M, Margiotta D, Rigon A, et al. Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors. J Rheumatol. 2009;36(2):295–297.
- Cerezo LA, Kuklová M, Hulejová H, et al. Progranulin is associated with disease activity in patients with rheumatoid arthritis. Mediators Inflamm. 2015;2015:740357. DOI:10.1155/2015/740357
- Tang W, Lu Y, Tian QY, et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science. 2011;332(6028):478–484.
- Abella V, Scotece M, Conde J, et al. The novel adipokine progranulin counteracts IL-1 and TLR4-driven inflammatory response in human and murine chondrocytes via TNFR1. Sci Rep. 2016;6:20356.
- Gomez R, Lago F, Gomez-Reino J, et al. Adipokines in the skeleton: influence on cartilage function and joint degenerative diseases. J Mol Endocrinol. 2009;43(1):11–18.
- Neumann E, Junker S, Schett G, et al. Adipokines in bone disease. Nat Rev Rheumatol. 2016;12(5):296–302.